Urology Lasers Market Analysis

Urology Lasers Market Analysis

To get key market trends

  Download Free Sample

The urology lasers market by type is categorized into holmium laser system, diode laser system, thulium laser system, and others. The holmium laser system segment garnered USD 411.5 million revenue size in the year 2022. These lasers cater a wide range of applications in treating kidney stones, bladder tumors, urethral strictures, and benign prostatic hyperplasia (BPH). Holmium lasers are particularly effective in fragmenting kidney stones, reducing patient discomfort, and minimizing the need for invasive procedures thereby, surging patient preference.
 

For instance, the Lumenis Pulse 120H holmium laser system integrated with MOSES technology from Boston Scientific Corporation represents a groundbreaking and patent-protected pulse delivery innovation. This advanced technology significantly enhances energy transmission, leading to highly efficient lithotripsy treatments compared to conventional holmium pulse systems. With ongoing technological advancements, these lasers offer enhanced efficiency and control during procedures.
 

On the basis of application, the urology lasers market is segmented as benign prostatic hyperplasia (BPH), urolithiasis, non-muscle-invasive bladder cancer (NMIBC), and others. The BPH segment accounted for over 38% market share in the year 2022. Benign prostatic hyperplasia is a prevalent condition affecting aging males. For instance, as per the National Institutes of Health, the prevalence of BPH experiences a notable increase after the age of 40, with a range of 8% to 60% observed among individuals by the time they reach 90 years of age, leading to increasing demand for effective treatment options.
 

Moreover, urology lasers offer a minimally invasive alternative to traditional surgeries, providing reduced discomfort and faster recovery. Their efficacy and precision in treating BPH by accurately ablating excess prostate tissue while preserving healthy tissue will contribute to improved patient outcomes and satisfaction. Growing awareness and acceptance of urology lasers in BPH treatment, along with technological advancements will spur the industry gains.
 

Based on end-use, the urology lasers market is segmented into hospitals, specialty clinics, and others. The hospitals segment is predicted to witness the highest progression at 5.5% CAGR by 2032. The growing healthcare infrastructure, integration of advanced technologies, and presence of skilled healthcare professionals for complex urological procedures. Furthermore, high patient volume among facilities and favorable reimbursement policies for urological procedures will drive the adoption rate of the business.  
 

U.S. urology lasers market accounted for USD 414.5 million market size in 2022. Advanced healthcare infrastructure equipped with state-of-the-art hospitals and a strong presence of skilled professionals for urological treatments in the U.S. is poised to stimulate industry revenue expansion potential. The rising prevalence of urological conditions, combined with high healthcare spending and favorable reimbursement policies will foster the demand for urology lasers. Additionally, a well-informed population and growing awareness of the benefits of urology lasers.